Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

AJ Ifi27 Interferon, alpha-inducible protein 2716.322.4117.75 Ifit3 Interferon-induced protein with tetratricopeptide repeats 310.491.753.44 C2 Complement component 22.882.63n/a Ifitm1 Interferon-induced transmembrane protein 12.861.76n/a MMP2 Matrix metallopeptidase 22.772.54n/a IL7 Interleukin 72.621.69n/a H2-T23 Histocompatibility 2, T region locus 232.564.41n/a Ifitm3 Interferon-induced transmembrane protein 32.501.65n/a Vdr Vitamin D (1,25-dihydroxyvitamine D3) receptor2.372.18n/a Tnfaip2 Tumor necrosis factor, alpha-induced protein 22.281.57n/a Csf1 Colony stimulating factor 12.251.81n/a CCL9 Chemokine (C-C motif) ligand 92.231.992.79 Ltbp1 Latent transforming growth factor beta binding protein 12.201.53n/a Pde4b Phosphodiesterase 4B, cAMP-specific2.141.611.73 H2-Q5 Histocompatibility 2, Q region locus 52.002.63n/a Slc1a3 Solute carrier family 1 (glial high affinity glutamate transporter), member 31.995.59n/a Angptl4 Angiopoietin-like 41.981.93n/a Gch1 GTP cyclohydrolase 11.942.483.14 Bdnf Brain-derived neurotrophic factor1.931.54n/a P2rx4 Purinergic receptor P2X, ligand-gated ion channel 41.861.82n/a Tgif1 TGFB-induced factor homeobox 11.822.38n/a Serpinh1 Serpin peptidase inhibitor, clade H (heat shock protein 47)1.761.531.64 Stat1 Signal transducer and activator of transcription 11.671.77−1.72 Ccnd1 Cyclin D11.641.571.66 Dab2 Disabled 2, mitogen-responsive phosphoprotein1.621.79n/a Nfkbie Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon1.60n/a1.54 Tlr2 Toll-like receptor 21.581.75n/a Bmpr2 Bone morphogenetic protein receptor, type II1.501.58n/a Actn3 Actinin, alpha 3−1.50−1.50n/a Tlr4 Toll-like receptor 4−1.53n/a−1.56 Rgs16 Regulator of G-protein signaling 16−1.54−1.64n/a Dpp3 Dipeptidyl-peptidase 3−1.56−1.63n/a Myh7 Myosin, heavy chain 7 (type I)−1.65−1.87n/a Id1 Inhibitor of DNA binding 1−1.72−1.53−1.59 IL1b Interleukin 1 beta−1.733.05−2.89 Cdkn1c Cyclin-dependent kinase inhibitor 1C (p57, kip2)−1.75−18.102.61 Mef2c Myocyte enhancer factor 2C−1.80−1.86−2.27 Btrc Beta-transducin repeat containing E3 ubiquitin protein ligase−1.89−1.50n/a Igf1 Insulin-like growth factor 1−1.91−1.71n/a Tgfb1 Transforming growth factor, beta 1−1.961.58−2.56 Tgfb2 Transforming growth factor, beta 1−2.00n/a−1.84 Musk Muscle, skeletal, receptor tyrosine kinase−2.03−4.73−1.90 Myoz2 Myozenin 2−2.88−1.68n/a Sgcg Sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)−3.01−1.83−1.72 Myl3 Myosin, light chain 3, skeletal slow−3.07−2.42−1.53 Myf6 Myogenic factor 6−4.13−3.53−1.94 Myh1 Myosin, heavy chain 1 (type IIx/d)−5.891.91n/aFold-change values of Illumina Gene array transcript subset which showed significant modulation by WT-M1 co-culture vs.

Source: M1 and M2a macrophages exert different molecular effects on WT and dysferlin-deficient myoblasts. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

To test the roles of the two macrophage phenotypes on regeneration in dysferlin-deficient muscle, we developed an in vitro co-culture model of macrophages and muscle cells.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Upregulated IL-1β in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophages

Study design awaiting verification · Skeletal Muscle · 2015

Original publication title

Upregulated IL-1β in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophages

Tatiana V. Cohen; Gina M. Many; Bryan D. Fleming; Viola F. Gnocchi; Svetlana Ghimbovschi; David M. Mosser; Eric P. Hoffman; Terence A. Partridge

© Cohen et al. 2015

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

We propose that the inhibitory effects of M1 macrophages on myogenesis are mediated by IL-1β signals and suppression of the M1-mediated immune response may improve muscle regeneration in dysferlin deficiency. Our studies identify a potential therapeutic approach to promote muscle regeneration in dystrophic muscle.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Loss-of-function mutations in the dysferlin gene (DYSF) result in a family of muscle disorders known collectively as the dysferlinopathies. Dysferlin-deficient muscle is characterized by inflammatory foci and macrophage infiltration with subsequent decline in muscle function. Whereas macrophages function to remove necrotic tissue in acute injury, their prevalence in chronic myopathy is thought to inhibit resolution of muscle regeneration. Two major classes of macrophages, classical (M1) and alternative (M2a), play distinct roles during the acute injury process. However, their individual roles in chronic myopathy remain unclear and were explored in this study.

Source: Background

Abstract: What methods does the paper describe?

To test the roles of the two macrophage phenotypes on regeneration in dysferlin-deficient muscle, we developed an in vitro co-culture model of macrophages and muscle cells. We assayed the co-cultures using ELISA and cytokine arrays to identify secreted factors and performed transcriptome analysis of molecular networks induced in the myoblasts.

Source: Methods

Abstract: Results

Dysferlin-deficient muscle contained an excess of M1 macrophage markers, compared with WT, and regenerated poorly in response to toxin injury. Co-culturing macrophages with muscle cells showed that M1 macrophages inhibit muscle regeneration whereas M2a macrophages promote it, especially in dysferlin-deficient muscle cells. Examination of soluble factors released in the co-cultures and transcriptome analysis implicated two soluble factors in mediating the effects: IL-1β and IL-4, which during acute injury are secreted from M1 and M2a macrophages, respectively. To test the roles of these two factors in dysferlin-deficient muscle, myoblasts were treated with IL-4, which improved muscle differentiation, or IL-1β, which inhibited it.

Importantly, blockade of IL-1β signaling significantly improved differentiation of dysferlin-deficient cells.

Source: Results

Abstract: Conclusions

We propose that the inhibitory effects of M1 macrophages on myogenesis are mediated by IL-1β signals and suppression of the M1-mediated immune response may improve muscle regeneration in dysferlin deficiency. Our studies identify a potential therapeutic approach to promote muscle regeneration in dystrophic muscle.

Source: Conclusions
Authors’ abstract

Background

Loss-of-function mutations in the dysferlin gene (DYSF) result in a family of muscle disorders known collectively as the dysferlinopathies. Dysferlin-deficient muscle is characterized by inflammatory foci and macrophage infiltration with subsequent decline in muscle function. Whereas macrophages function to remove necrotic tissue in acute injury, their prevalence in chronic myopathy is thought to inhibit resolution of muscle regeneration. Two major classes of macrophages, classical (M1) and alternative (M2a), play distinct roles during the acute injury process. However, their individual roles in chronic myopathy remain unclear and were explored in this study.

Methods

To test the roles of the two macrophage phenotypes on regeneration in dysferlin-deficient muscle, we developed an in vitro co-culture model of macrophages and muscle cells. We assayed the co-cultures using ELISA and cytokine arrays to identify secreted factors and performed transcriptome analysis of molecular networks induced in the myoblasts.

Results

Dysferlin-deficient muscle contained an excess of M1 macrophage markers, compared with WT, and regenerated poorly in response to toxin injury. Co-culturing macrophages with muscle cells showed that M1 macrophages inhibit muscle regeneration whereas M2a macrophages promote it, especially in dysferlin-deficient muscle cells. Examination of soluble factors released in the co-cultures and transcriptome analysis implicated two soluble factors in mediating the effects: IL-1β and IL-4, which during acute injury are secreted from M1 and M2a macrophages, respectively. To test the roles of these two factors in dysferlin-deficient muscle, myoblasts were treated with IL-4, which improved muscle differentiation, or IL-1β, which inhibited it.

Importantly, blockade of IL-1β signaling significantly improved differentiation of dysferlin-deficient cells.

Conclusions

We propose that the inhibitory effects of M1 macrophages on myogenesis are mediated by IL-1β signals and suppression of the M1-mediated immune response may improve muscle regeneration in dysferlin deficiency. Our studies identify a potential therapeutic approach to promote muscle regeneration in dystrophic muscle.

Publication and source details

Original title: Upregulated IL-1β in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophages

Tatiana V. Cohen; Gina M. Many; Bryan D. Fleming; Viola F. Gnocchi; Svetlana Ghimbovschi; David M. Mosser; Eric P. Hoffman; Terence A. Partridge

Skeletal Muscle · 2015

© Cohen et al. 2015https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T20:25:37.187118+00:00

DOI: 10.1186/s13395-015-0048-4 · PMC4527226